Literature DB >> 15921995

Methylphenidate and amphetamine modulate differently the NMDA and AMPA glutamatergic transmission of dopaminergic neurons in the ventral tegmental area.

B Prieto-Gómez1, A M Vázquez-Alvarez, J L Martínez-Peña, C Reyes-Vázquez, P B Yang, N Dafny.   

Abstract

Behavioral and neurochemical studies suggest that the induction of behavioral sensitization to psychostimulants involves transient changes at the synapses of the ventral tegmental area's dopaminergic neurons (VTA-DA). Differences in the behavioral response to amphetamine (Amph) and methylphenidate (MPD) were observed. In an attempt to understand these behavioral differences at the neuronal level, the dose-response characteristics of these two psychostimulants on electrophysiologically identified VTA-DA neurons at the glutamatergic synapse were investigated. Miniature excitatory post-synaptic currents (mEPSCs) and electrically induced EPSCs were recorded from horizontal midbrain slices of rats that had been pretreated intraperitoneally (i.p.) with saline (control), Amph (2.5, 5.0, 10.0 or 20.0 mg/kg), or MPD (2.5, 5.0, 10.0 or 20.0 mg/kg) 24 h before the recording. Perfusion of Amph through the bath (2.5, 5.0, 10.0 or 20.0 microM) increased the frequency (p<0.01) and the amplitude (p<0.05) of mEPSCs in dose-response characteristics, while MPD perfusion through the bath (2.5, 5.0, 10.0, or 20.0 microM) increased only the frequency (p<0.05) of the mEPSC. Both psychostimulants increased the prefrontal cortex's (PFC) glutamatergic EPSC in the VTA-DA neurons. However, only the higher doses of MPD induced significant effects (p<0.05) on the N-methyl-D-aspartate (NMDA) receptor-mediated EPSC but had no effects on the EPSC mediated by alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA/kainate) receptors. Contrarily, Amph increased both kinds of mediated EPSC, but mainly the EPSC mediated by AMPA/kainate receptors (p<0.01). These electrophysiological differences could represent the underlying mechanism responsible for the differences of behavioral effects, such as behavioral sensitization, elicited by MPD and Amph.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15921995     DOI: 10.1016/j.lfs.2004.10.076

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  14 in total

1.  Nucleus accumbens neuronal activity in freely behaving rats is modulated following acute and chronic methylphenidate administration.

Authors:  Samuel L Chong; Catherine M Claussen; Nachum Dafny
Journal:  Brain Res Bull       Date:  2012-01-13       Impact factor: 4.077

2.  Combined action of MK-801 and ceftriaxone impairs the acquisition and reinstatement of morphine-induced conditioned place preference, and delays morphine extinction in rats.

Authors:  Yaodong Fan; Haichen Niu; Joshua D Rizak; Ling Li; Guimei Wang; Liqi Xu; He Ren; Hao Lei; Hualin Yu
Journal:  Neurosci Bull       Date:  2012-10-03       Impact factor: 5.203

3.  Caudate neuronal recording in freely behaving animals following acute and chronic dose response methylphenidate exposure.

Authors:  Catherine M Claussen; Nachum Dafny
Journal:  Pharmacol Biochem Behav       Date:  2015-06-20       Impact factor: 3.533

4.  Acute and chronic methylphenidate administration in intact and VTA-specific and nonspecific lesioned rats.

Authors:  Stephanie A Ihezie; Ming M Thomas; Nachum Dafny
Journal:  J Neural Transm (Vienna)       Date:  2019-01-08       Impact factor: 3.575

5.  Topiramate via NMDA, AMPA/kainate, GABAA and Alpha2 receptors and by modulation of CREB/BDNF and Akt/GSK3 signaling pathway exerts neuroprotective effects against methylphenidate-induced neurotoxicity in rats.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Sulail Fatima; Tabassom Beiranvand; Shiva Mozaffari
Journal:  J Neural Transm (Vienna)       Date:  2017-08-09       Impact factor: 3.575

6.  PharmGKB summary: methylphenidate pathway, pharmacokinetics/pharmacodynamics.

Authors:  Tyler Stevens; Katrin Sangkuhl; Jacob T Brown; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2019-08       Impact factor: 2.089

7.  Methylphenidate Increases Glutamate Uptake in Bergmann Glial Cells.

Authors:  Alain M Guillem; Zila Martínez-Lozada; Luisa C Hernández-Kelly; Esther López-Bayghen; Bruno López-Bayghen; Oscar A Calleros; Marco R Campuzano; Arturo Ortega
Journal:  Neurochem Res       Date:  2015-09-18       Impact factor: 3.996

Review 8.  In vitro study methodologies to investigate genetic aspects and effects of drugs used in attention-deficit hyperactivity disorder.

Authors:  Edna Grünblatt; Jasmin Bartl; Zoya Marinova; Susanne Walitza
Journal:  J Neural Transm (Vienna)       Date:  2012-07-26       Impact factor: 3.575

Review 9.  Glutamatergic substrates of drug addiction and alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  Biochem Pharmacol       Date:  2007-06-30       Impact factor: 5.858

10.  Nucleus accumbens neuronal activity correlates to the animal's behavioral response to acute and chronic methylphenidate.

Authors:  Catherine M Claussen; Samuel L Chong; Nachum Dafny
Journal:  Physiol Behav       Date:  2014-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.